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Osteolysis of the distal clavicle may result from a
number of local and systemic diseases. Progressive
systemic sclerosis, rheumatoid arthritis, gout, Gor-
ham’s disease, infection and hyperparathyreoidism
may all lead to locally restricted bone destruction.
Osteolysis of the distal clavicle has also been
reported in patients with a history of weight lifting,
baseball, handball, pneumatic jackhammer use and
also spinal cord injury.5—7,15,17,18 In these cases, the
longstanding stress on upper extremity has been
suggested to lead to repetitive microtrauma with
a consequence of osteolysis.
Shoulder trauma with acromioclavicular (AC)
separation leads to distal clavicle osteolysis with
an incidence of 1—21%.20 However, osteolysis has
also been repeatedly described in patients with no
radiological pathologies after the injury. Although
usually self-limiting within 18 months, post-trau-
matic osteolysis may lead to irreversible vanishing
of the distal 0.5—3 cm of the clavicle.12 However, a* Corresponding author. Tel.: +358 2 333 7226;
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Open access under the Elsevier OA license.recent case report suggested that conservative
therapy may not only lead to healing of the distal
clavicle, but also to normalization of joint space
dimension.9 The pathogenesis of the disease
remains unknown. Therefore, it is not surprising
that the therapies described in papers concerning
the disease show great variability. Although immo-
bilisation is generally accepted as the first line
therapy and although it may decrease the duration
of the lytic phase, it may not suppress the early
manifestation of the disease.12 However, reliable
studies focusing on the effect of other current
therapies such as anti-inflammatory agents, cryo-
therapy, intra-articular corticosteroid injections,
short wave diathermy and operative resection of
the distal clavicle are still missing.
Alendronate is a nitrogen-containing bisphospho-
nate thathasahighaffinity tobonehydroxyapatite. It
mediates its anti-resorptive effect by being locally
released from the bone surface during bone resorp-
tion and thereafter inhibiting the mevalonate path-
way in the osteoclast.8 This leads to the impaired
prenylationofproteins,disturbedosteoclast function
and cessation of bone resorption.1 For these reasons,
bisphosphonates are widely used in prevention and
treatment of primary and corticosteroid-induced
346 M.T.K. Mulari et al.osteoporosis, Paget’s disease of bone and hypercal-
cemia caused by malignancies and metastases-dis-
eases where the loss of bone is the pathological
hallmark.
The present paper describes a patient with a
history of trauma-induced osteolysis of the distalFigure 1 Twelve hours after the trauma conventional radio
clavicular joint (B). The joint was 4 mm wide on the left and 3
osteolysis of the clavicle was observed at its acromial extremit
and widening of the joint up to 6 mm (D). MRI showed fragm
marrow oedema in the distal clavicle and joint effusion on T2-we
the initiation of the alendonate treatment, cortex reformation
weeks of alendronate administration, clavicular bone marrow
bone in distal clavicle and a mildly prominent joint capsule we
Conventional radiographs proved further healing of the claviclclavicle, and its successful treatment with alendro-
nate administration. Our results suggest that by
inhibiting pathologically increased osteoclastic
bone resorption, bisphosphonate therapy is relevant
in preventing further bone degradation after the
diagnosis of the post-traumatic osteolysis.graphs revealed gradus I subluxation in the left acromio-
mm on the contralateral side (A). At 8 weeks progressive
y. Conventional radiographs showed cortical bone erosions
entation of the subchondral bone, cystic formation, bone
ighted fat-suppressed coronal images (C). Fourweeks after
and bone fragment ossification were obvious (E). After 11
oedema had diminished. Cystic lesions of the subchondral
re still observed (F, proton density-weighted axial image).
e (G). c: clavicle; a: acromion; ssm: supraspinatus muscle.
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A 20-year-old male accidentally hit his left shoulder
on the ground during military service in December
2001. At the emergency unit, the acromioclavicular
(AC) joint was tender and the distal clavicle was
slightly prominent. Radiographs revealed a type I
AC-separation injury with a mild vertical displace-
ment. The AC distance was 3 mm on the right and
4 mm on the left (Fig. 1A and B). Abduction of the
upper left extremity was painful. At this time, all
inciting activities were avoided and occasional non-
steroidal anti-inflammatory drugs were admini-
strated for the pain.
After 8 weeks, the stabbing shoulder pain during
sleep and daytime activities persisted. Abduction
and rotation movements of the left arm were now
painless, but compression of the distal clavicle was
painful. Radiographs suggested post-traumatic
osteolysis (Fig. 1D).
Three weeks later, the AC distance was 5—
6 mm, and with stress provocation test 6 mm.
The MRI revealed marrow oedema in the distal
clavicle, joint effusion and erosions of the sub-
chondral cortical bone (Fig. 1C). Acromion and the
glenohumeral joint were unaffected. Crepitus over
the left AC joint was obvious. Due to the patho-
logically proceeding loss of bone, we initiated oral
administration of alendronate (Fosamax1, Merck
& Co. Inc., Whitehouse Station, NJ, U.S.A) to slow
down the increased osteoclastic activity. During
the first week, 70 mg was administered on two
successive days. Thereafter, the weekly dose was
70 mg.
After 15 weeks of the incident, extensive abduc-
tion was still slightly painful, but compression of the
AC joint was painless. In conventional radiographs,
the acromioclavicular distance was still 6 mm.
Sclerotic cyst formation and bone fragment ossifica-
tion and fusion with the clavicle were also evident
(Fig. 1E). Thus, the progression of clavicle osteolysis
was ceased during the first month of alendronate
administration.
After 11 weeks of alendronate therapy, conven-
tional radiographs showed a 5 mm widening of the
AC joint in stress radiographs (Fig. 1G). Oedema
had diminished in the clavicle although small ero-
sions at the distal clavicle were observed. There
was no effusion or synovitis in the AC joint, and
cortical bone had been re-formed (Fig. 1F).
Although almost fully functional and painless, some
physical stress such as heavy burden was still pro-
vocative of stabbing pain in the shoulder. No cre-
pitus was observed and the healing of the process
was evident. No anisocoria was observed at any
time during follow-up.Discussion
A wide diversity of therapies on the post-traumatic
osteolysis has been described. However, reliable
evidence showing their effect is missing. Although
a self-limiting disease with a good prognosis, under-
standing the pathogenesis of the post-traumatic
osteolysis is of importance in the view of discovering
and practising an adequate therapy. Unfortunately,
this issue is currently covered in a mist as well.
Histological sections of the osteolytic clavicle
aftermore than 6months after the injury have shown
hyperplastic synovium, vascular proliferation, oede-
matous tissue, bony remodelling and chronic inflam-
matory cells but no sign of necrosis, hemorrhage or
acute inflammation.7 Asano et al. reported the pre-
sence of inflammatory cells in bone marrow of both
clavicle and acromion, fibrous tissue with vascular
proliferation covering the distal clavicle and the
presence of multinuclear giant cells 5 months after
the injury,3 while Levine et al. showed that after 18
months of the initial trauma there was evidence for
vascular proliferation, periosteal hypertrophy, vil-
lous hyperplasia and tiny fragments of necrotic
bone.12 Others have suggested bone and articular
cartilage destruction and replacement by fibrous
tissue, detritus in marrow spaces, subchondral cyst
formation and sclerotic bone generally viewed as
indicative of avascular necrosis.4,14,16 Osteoclasts
are the only known cells capable of effective bone
resorption. Thus, it could be either an increase in the
number of osteoclasts or up-regulation of the activity
of thepre-existing osteoclasts or both,which leads to
the postraumatic osteolysis of distal clavicle.
Several mechanisms by which trauma induces
osteolysis have been suggested. An injury may lead
toanautonomicnervous systemdysfunction resulting
in secondary changes in blood supply. The suggestion
is supported by observations of anisocoria among
patients.13 The resulting hypervascularity in the joint
may lead to catabolic hyperemia, ischemic necrosis
of bone, and finally osteoclastic bone resorption.
However, disturbances in neuropeptide secretion
may also play a more direct role in orchestrating
bone remodelling, since neuronal cells containing
peptides affecting the behaviour of osteoblasts and
osteoclasts are present in bone.11 Denervation also
affects fracture healing and local neuropeptide
expression in bone, which emphasises the potential
role of nerve damage in post-traumatic osteolysis.10
The stimuli leading to post-traumatic osteolysis
are likely to involvemany cell types present in bone.
Osteoblasts, bone marrow stromal cells and macro-
phages as well as other cells could release inflam-
matory cytokines such as IL-1, IL-6 and TNF-a, which
lead to osteoclast activation either directly or indir-
348 M.T.K. Mulari et al.ectly via osteoblasts and RANK-ligand-NF-kB or M-
CSF signalling pathways.19 It is thus exciting that
several authors have reported the existence of
inflammatory cells in the bone marrow of distal
clavicle during the post-traumatic osteolysis.3,7 A
chronic inflammation may also lead to a local lac-
tate production and acidic environment formation,
which would stimulate osteoclasts and contribute to
the mineralized matrix dissolution directly as well.2
Our results suggest that no matter what media-
tors are associated with the osteolytic process, the
cellular pathway in osteolysis involves in the end the
activity of the osteoclast and as long as the phar-
maceutical agent can inhibit the osteoclast func-
tion, improvement could be anticipated. Thus, it is
likely that not only alendronate but also other
bisphophonates may have a beneficial effect in
treating and preventing post-traumatic osteolysis.
However, although inhibiting resorption, no direct
anabolic effect of alendronate on bone has been
shown. Therefore, it is likely that the change from a
6 mm to a 5 mm diastasis in the injured acromio-
clavicular joint of the current patient was not likely
a direct cause of alendronate treatment but rather a
radiographic finding noted by the restoration of
bone mass where the bone resorption had ceased.
Finally, although the patient’s radiographic and
symptomatic findings significantly improved during
the alendronate treatment, without a concurrent
control patient or group of patients we cannot state
for sure if alendronate caused these improvements.
Further randomized and placebo-controlled pro-
spective trial is thus needed to confirm or reject
this theoretically appealing way of treatment.Acknowledgements
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